Health Care Industry
Industry: Email Alert RSS FeedAdvances in DNA vaccines
Nurse Practitioner, Jan 2002 by Simmerman, James Mark
21. Tang DL, DeVit M, Johnston SA: Genetic immunization is a simple method for eliciting and immune response. Nature 1992;356:152-54.
22. Jones DH, Corris S, Donald S, et al.: Poly-encapsulated DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration. Vaccine 1997;15:814-17.
23. Fynan EF, Websater RG, Fuller DH, et al.: DNA vaccines: Protective immunizations by parenteral, mucosal and gene-gun inoculations. Proc Nat] Acad Sci USA 1993;90:11478-82.
24. Wang B, Dang K, Agadjanyan MG, et al.: Mucosal immunization with a DNA vaccine induces immune responses against HIV- at a mucosal site. Vaccine 1997;15:821-25.
- Most Popular Articles in Health
- Fuel your workout: exercisers who eat before they work out have more energy ...
- Soothe a dry, itchy scalp: 5 easy expert solutions
- Cocktails and calories: Beer, wine and liquor calories can really add up. ...
- The sour truth about apple cider vinegar - evaluation of therapeutic use
- The, six best supplements you've never heard of: these secret weapons can ...
- More »
25. Akbari 0, Panjwani N, Garcia S, et al.: DNA vaccination: Transfection and activation of dendritic cells as key events for immunity. J Exp Med 1999;189:169-78. 26. Yang NS, Burkholder J, Roberts B, et al.: In vivo gene transfer to mammalian
somatic cells by particle bombardment. Proc Natl Acad Sci USA 1990;87:9568. 27. Medina E, Guzman CA: Use of live bacterial vectors for antigen delivery: Potential and limitations. Vaccine 2001; 19:1573-80.
28. Darji A, Zur Lage S, Garbe AI, et al.: Oral delivery of DNA vaccines using attenuated Salmonella typhimurium as carrier. FEMS Immunol Med Microbiol 2000;27(4):299-304.
29. Barnett SW, Rajasekar S, Legg H, et al.: Vaccination with HIV- 1 gp120 DNA induces immune responses that are boosted by a recombinant gp 120 protein subunit. Vaccine 1997;15:1049-56.
30. Kent SJ, Zhao A, Best SJ, et al.: Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus. J Virol 1998;72:10180-88.
31. Ramshaw IA, Ramsay Al: The prime-boost strategy: Exciting prospects for improved vaccination. Immunol Today 2000;21(45):163-65.
32. Spack EG, Sorgi FL: Developing non-viral DNA delivery systems for cancer
and infectious disease. Drug Discovery Today 2001;6(4):186-97.
33. Da Silva DM, Eiben GL, Fausch SC, et al.: Cervical cancer vaccines: Emerging concepts and developments. J Cell Physiol 2001;186(2):169-82.
34. Mor G, Singla M, Steinberg AD, et al.: Do DNA vaccines induce autoimmune disease? Hum Gene Ther 1997;8:293-300.
35. Le TP, Coonan KM, Hedstrom RC, et al.: Safety, tolerability and humoral responses after intramuscular administration of a malaria DNA vaccine to health adult volunteers. Vaccine 2000;18:1893-901.
36. Nichols WW, Ledwith BJ, Manam SV, et al.: Potential DNA vaccine integration into host cell genome. Ann NY Acad Sci 1995;772:30-39.
37. Martin T, Parker SE, Hedstrom R, et al.: Plasmid DNA malaria vaccine: The potential for genomic integration following intramuscular injection. Hum Gene Ther 1999;10:759-68.
38. Ishii KJ, Weiss W Kinman DM: Prevention of neonatal tolerance by plasmid encoding granulocyte-macrophage colony stimulating factor. Vaccine 1999;18(7-8):703-10.
39. Wang Y, Xiang Z, Pasquini S, et al.: Immune response to neonatal genetic immunization. Virology 1997;228:278-84.